AI assistant
Sending…
RESMED INC — Director's Dealing 2026
Mar 3, 2026
30071_dirs_2026-03-03_023db08e-5e62-4e09-b246-ebecdf10421c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2026-03-02
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-03-02 | ResMed Common Stock | S | 1000 | $254.30 | Disposed | 84495 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29
Director's Dealing
2026
Jan 9